Products & Tech | Page 48 of 63

Bydureon Receives Positive Opinion From The European Medicines Agency

Eli Lilly and Company, Amylin Pharmaceuticals and Alkermes announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending approval of Bydureon for injection in the European Union for the treatment of type 2 diabetes in combination with...

Victoza More Effective Than Competitors New Study Shows

A new meta study presented by Novo Nordisk at the 20th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists (AACE) shows that regardless of baseline A1C, once-daily Victoza (liraglutide [rDNA origin] injection) 1.8 mg consistently helped more patients achieve blood sugar control than...

Sanofi-aventis Announces Positive Results for Lixisenatide

Sanofi-aventis announced today that lixisenatide, a once-daily GLP-1 receptor agonist under development for people with type 2 diabetes, achieved its primary efficacy objective of significant HbA1c reduction and improved glycemic control from...

Medtronic Launches New Improved CGM Sensor

Medtronic has launched the Enlite Sensor, the newest and most advanced glucose sensor for continuous glucose monitoring (CGM), in more than 35 countries outside of the United States. The new Enlite Sensor combines greater comfort with improved glucose sensor performance in both overall accuracy and detection of hypoglycemia...

Dietary Supplement May Help Control Type 2 Diabetes

A new study published in the Journal of Nutrition and Dietary Supplements has found that the natural dietary supplements, Sugar Crush and Sugar Crush Daily, were effective in reducing blood glucose levels in patients with type 2 diabetes...

Innovate or Die: The Medtronic Diabetes Advocacy Forum

What is next for Medtronic? What holds back new products, and what is being done to keep development moving forward?

Continuous Glucose Monitoring Improves Blood Sugar Control In Type 1 Diabetics

A new study designed to evaluate the effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes has found that continuous glucose monitoring both reduces the amount of time spent by type 1 diabetes patients in hypoglycemia and improves HbA1c levels. The results appear in the April addition of Diabetes Care....

Use of Bariatric Surgery in Type 2 Diabetes Patients Encouraged

An International Diabetes Federation (IDF) paper calls for bariatric surgery to be considered earlier in the treatment of eligible type 2 diabetes patients, to help stem the serious complications that can result from diabetes. The position paper was presented to leading experts at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes ...

Levemir Better for Treating Young Children with Type 1 Diabetes Than Human Basal Insulin

New clinical trial data just published in Pediatric Diabetes shows that Levemir (insulin detemir), Novo Nordisk’s basal insulin analogue, is an equally efficacious treatment option for two to five year-old children with type 1 diabetes, compared with human basal insulin, but is associated with lower hypoglycemic risk. Children with type 1 diabetes who are aged under six years...

Victoza Approved for Treatment of Type 2 Diabetes in China

The Chinese State Food and Drug Administration (SFDA) has approved Victoza for the treatment of type 2 diabetes. Diabetes is a rapidly growing disease in China, and Victoza offers a unique treatment option by effectively reducing HbA1c and weight with a low risk of hypoglycemia in people with type 2 diabetes inadequately controlled by oral anti-diabetic agents...